Trade Dr. Martens plc - DOCS.L CFD

Trading Conditions
Spread0.0165
Long position overnight fee
Long position overnight fee

Margin. Your investment
£1,000.00
Overnight fee
Charges from full value of position
-0.02529 %
(-£1.01)

Trade size with leverage ~ £5,000.00

Short position overnight fee ~ £4,000.00


-0.02529%
Short position overnight fee
Short position overnight fee

Margin. Your investment
£1,000.00
Overnight fee
Charges from full value of position
0.003373 %
(£0.13)

Trade size with leverage ~ £5,000.00

Short position overnight fee ~ £4,000.00


0.003373%
Overnight fee time21:00 (UTC)
CurrencyGBP
Min traded quantity1
Margin20
Stock exchangeUnited Kingdom of Great Britain and Northern Ireland
Commission on trade10%

Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close0.7005
Open0.694
1-Year Change-59.02%
Day's Range0.694 - 0.727

Dr. Martens plc Company profile

About Dr Martens PLC

Dr. Martens plc is a United Kingdom-based company that designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Financial summary

BRIEF: For the six months ended 30 September 2021, Dr Martens PLC revenues increased 16% to £369.9M. Net income increased 65% to £48.6M. Revenues reflect Americas segment increase of 44% to £147.5M, Americas segment increase of 44% to £147.5M, Retail Sales - Total increase of 92% to £65.9M, Online Sales - Total increase of 10% to £82.6M. Net income benefited from Interest expense decrease of 75% to £5.1M (expense). Dividend per share totaled to £0.01.